Zentek (CVE:ZEN) Shares Up 8.6% – What’s Next?

Zentek Ltd. (CVE:ZENGet Free Report) shot up 8.6% on Tuesday . The stock traded as high as C$1.05 and last traded at C$1.01. 261,159 shares were traded during mid-day trading, an increase of 193% from the average session volume of 89,159 shares. The stock had previously closed at C$0.93.

Zentek Trading Up 3.1%

The company has a current ratio of 1.00, a quick ratio of 7.59 and a debt-to-equity ratio of 15.41. The firm has a fifty day simple moving average of C$0.80 and a two-hundred day simple moving average of C$0.94. The firm has a market cap of C$106.47 million, a PE ratio of -12.38 and a beta of 0.34.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.

Featured Stories

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.